companydata.dkUnibio USA ApS: Financial statements 2018
CVR: 38179845
Unibio USA ApS (CVR 38179845) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -15,000 and a net result of DKK -12,000. Equity amounted to DKK 31,000. The solvency ratio was 73.8%.
- Gross Profit
- -15,000 kr.
- Profit/Loss
- -12,000 kr.
- Equity
- 31,000 kr.
- Total Assets
- 42,000 kr.
- Employees
- 0
Keep an eye on Unibio USA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
As of June 15, 2018, Jakob Brix Christensen is registered as director of Unibio USA ApS.
As of June 15, 2018, Jesper Halling Pedersen has stepped down as director of Unibio USA ApS.
Unibio USA ApS has published its interim report for the period November 14, 2016 – December 31, 2017.
About Unibio USA ApS
Unibio USA ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Søren Olrik Eklund and David Richard Henstrom. The company is owned by UNIBIO A/S. In 2025, the company reported a net result of DKK -20,000 compared with DKK -26,000 the year before. Equity amounted to DKK 25,000.